绝经管理:以预防为视角
女性约三分之一的生命在绝经后度过,绝经发生在50岁左右。绝经过渡期即出现代谢与心血管风险,绝经后10-15年可发生体重增加与肥胖、代谢综合征、糖尿病、骨质疏松、关节炎、心血管疾病、痴呆和癌症,因此绝经是实施预防策略的重要时机。激素治疗可缓解症状和骨质疏松,并改善代谢与心血管健康;在60岁以下年轻绝经后女性中早期启用雌激素可持续降低死亡率,低风险女性风险-获益良好,且长期治疗可能并非必需。
要点
- 绝经是实施预防策略的重要时机,可改善生活质量并降低死亡率。
- 激素治疗对绝经症状和骨质疏松有效,并可改善代谢与心血管健康。
- 60岁以下年轻绝经后女性早期启用雌激素可持续降低死亡率,低风险女性风险-获益良好。
核心结论
- 绝经是实施预防策略的重要时机,可改善生活质量并降低死亡率;早期启用激素治疗在60岁以下年轻绝经后女性中可持续降低死亡率,低风险女性风险-获益良好。
研究设计与样本
- 原文为综述,检索范围未报告。
主要发现
- 女性约三分之一的生命在绝经后度过,绝经发生在50岁左右。
- 绝经过渡期出现代谢和心血管疾病风险,绝经后10-15年发生体重增加与肥胖、代谢综合征、糖尿病、骨质疏松、关节炎、心血管疾病、痴呆和癌症。
- 激素治疗对绝经症状和骨质疏松有效,并可改善代谢和心血管健康。
- 在60岁以下年轻绝经后女性中早期启用雌激素可持续降低死亡率,低风险女性风险-获益良好;前瞻性数据显示长期治疗可能并非必需。
关键数值与推荐
- 原文未报告具体推荐条款或数值标准。
临床怎么用
- 原文提出绝经是实施预防策略的重要时机,并呈现了治疗绝经症状和无症状疾病的多种策略,包括激素治疗。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Women spend approximately one-third of their lives with menopause, which occurs around 50 years of age. It is now appreciated that several important metabolic and cardiovascular disease risks emerge during the menopausal transition. Many important conditions occur 10-15 years after menopause, including weight gain and obesity, metabolic syndrome, diabetes, osteoporosis, arthritis, cardiovascular disease, dementia, and cancer; therefore, the occurrence of menopause heralds an important opportunity to institute preventative strategies. These strategies will lead to improved quality of life and decreased mortality. Various strategies are presented for treating symptoms of menopause and diseases that are asymptomatic. Among several strategies is the use of hormone therapy, which has efficacy for symptoms and osteoporosis, and can improve metabolic and cardiovascular health. When instituted early, which is key, in younger postmenopausal women (under 60 years) oestrogen has been found to consistently decrease mortality with a favourable risk-benefit profile in low-risk women. Prospective data show that long-term therapy might not be required for this benefit.
引用
- Lobo RA, Gompel A. Management of menopause: a view towards prevention. Lancet Diabetes Endocrinol. 2022. PMID: 35526556. doi:10.1016/S2213-8587(21)00269-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。